In summary, our work elucidated a novel mechanism regulating HCC cell proliferation that involves the antagonism of PTPN13 and IGF2BP1 and the control of c-Myc-induced metabolic reprogramming during hepatocarcinogenesis. The gene discussed is MYC; the disease is hepatocellular carcinoma.